menu toggle
COVID-19 : 리소스 센터 (자료 센터)
COVID-19에 대한 World Courier의 운영 업데이트 및 포괄적인 정보를 확인하십시오.

Biosimilars pipeline report: A guide for understanding the growing market

By Amerisourcebergen

To date, there have been 40 approvals and 29 launches in the U.S. biosimilars market

Biosimilars are a promising product category, one that can provide patients and doctors with more affordable treatment options. As this market matures, its pipeline continues to grow. This reference guide is a useful tool to visualize and understand the current product landscape and potential future of this emerging market.

Learn more about our biosimilar solutions

At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.